Jamshidi, M.; Fagerholm, R.; Muranen, T.A.; Kaur, S.; Potdar, S.; Khan, S.; Netti, E.; Mpindi, J.-P.; Yadav, B.; Kiiski, J.I.;
et al. High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome. Cancers 2021, 13, 2907.
https://doi.org/10.3390/cancers13122907
AMA Style
Jamshidi M, Fagerholm R, Muranen TA, Kaur S, Potdar S, Khan S, Netti E, Mpindi J-P, Yadav B, Kiiski JI,
et al. High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome. Cancers. 2021; 13(12):2907.
https://doi.org/10.3390/cancers13122907
Chicago/Turabian Style
Jamshidi, Maral, Rainer Fagerholm, Taru A. Muranen, Sippy Kaur, Swapnil Potdar, Sofia Khan, Eliisa Netti, John-Patrick Mpindi, Bhagwan Yadav, Johanna I. Kiiski,
and et al. 2021. "High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome" Cancers 13, no. 12: 2907.
https://doi.org/10.3390/cancers13122907
APA Style
Jamshidi, M., Fagerholm, R., Muranen, T. A., Kaur, S., Potdar, S., Khan, S., Netti, E., Mpindi, J.-P., Yadav, B., Kiiski, J. I., Aittomäki, K., Heikkilä, P., Saarela, J., Bützow, R., Blomqvist, C., & Nevanlinna, H.
(2021). High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome. Cancers, 13(12), 2907.
https://doi.org/10.3390/cancers13122907